Citation: | ZHANG Wenjing, XU Yaqi, HUANG Yiming, WANG Fenglin, WANG Aimin, WANG Qinghua, SHI Fuyan. Identification of immune molecular markers for ischemic stroke based on genomic data[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(6): 664-671. doi: 10.16462/j.cnki.zhjbkz.2024.06.008 |
[1] |
Collaborators G2S. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the global burden of disease study 2016 [J]. Lancet Neurol, 2019, 18(5): 439-458. DOI: 10.1016/S1474-4422(19)30034-1.
|
[2] |
Harston GWJ, Rane N, Shaya G, et al. Imaging biomarkers in acute ischemic stroke trials: a systematic review [J]. AJNR Am J Neuroradiol, 2015, 36(5): 839-843. DOI: 10.3174/ajnr.A4208.
|
[3] |
Zameer S, Siddiqui AS, Riaz R. Multimodality imaging in acute ischemic stroke [J]. Curr Med Imag Former Curr Med Imag Rev, 2021, 17(5): 567-577. DOI: 10.2174/1573405616666201130094948.
|
[4] |
Shi KB, Zou M, Jia DM, et al. tPA mobilizes immune cells that exacerbate hemorrhagic transformation in stroke [J]. Circ Res, 2021, 128(1): 62-75. DOI: 10.1161/CIRCRESAHA.120.317596.
|
[5] |
Iadecola C, Buckwalter MS, Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential [J]. J Clin Invest, 2020, 130(6): 2777-2788. DOI: 10.1172/JCI135530.
|
[6] |
Xu SB, Lu JN, Shao AW, et al. Glial cells: role of the immune response in ischemic stroke [J]. Front Immunol, 2020, 11: 294. DOI: 10.3389/fimmu.2020.00294.
|
[7] |
Nikolic D, Jankovic M, Petrovic B, et al. Genetic aspects of inflammation and immune response in stroke [J]. Int J Mol Sci, 2020, 21(19): 7409. DOI: 10.3390/ijms21197409.
|
[8] |
Wu F, Liu ZC, Zhou LH, et al. Systemic immune responses after ischemic stroke: from the center to the periphery [J]. Front Immunol, 2022, 13: 911661. DOI: 10.3389/fimmu.2022.911661.
|
[9] |
O'Connell GC, Petrone AB, Treadway MB, et al. Machine-learning approach identifies a pattern of gene expression in peripheral blood that can accurately detect ischemic stroke [J]. NPJ Genom Med, 2016, 1: 16038. DOI: 10.1038/npjgenmed.2016.38.
|
[10] |
Yang XT, Wang PY, Yan SQ, et al. Study on potential differentially expressed genes in stroke by bioinformatics analysis [J]. Neurol Sci, 2022, 43(2): 1155-1166. DOI: 10.1007/s10072-021-05470-1.
|
[11] |
Stamova B, Jickling GC, Ander BP, et al. Gene expression in peripheral immune cells following cardioembolic stroke is sexually dimorphic [J]. PLoS One, 2014, 9(7): e102550. DOI: 10.1371/journal.pone.0102550.
|
[12] |
Bhattacharya S, Andorf S, Gomes L, et al. ImmPort: disseminating data to the public for the future of immunology [J]. Immunol Res, 2014, 58(2-3): 234-239. DOI: 10.1007/s12026-014-8516-1.
|
[13] |
Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies [J]. Nucleic Acids Res, 2015, 43(7): e47. DOI: 10.1093/nar/gkv007.
|
[14] |
Chen L, Zhang YH, Wang SP, et al. Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways [J]. PLoS One, 2017, 12(9): e0184129. DOI: 10.1371/journal.pone.0184129.
|
[15] |
Chin CH, Chen SH, Wu HH, et al. CytoHubba: identifying hub objects and sub-networks from complex interactome [J]. BMC Syst Biol, 2014, 8 (Suppl 4): S11. DOI: 10.1186/1752-0509-8-S4-S11.
|
[16] |
Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles [J]. Nat Methods, 2015, 12(5): 453-457. DOI: 10.1038/nmeth.3337.
|
[17] |
Lorne E, Dupont H, Abraham E. Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine? [J]. Intensive Care Med, 2010, 36(11): 1826-1835. DOI: 10.1007/s00134-010-1983-5.
|
[18] |
Lissauer ME, Johnson SB, Bochicchio GV, et al. Differential expression of toll-like receptor genes: sepsis compared with sterile inflammation 1 day before sepsis diagnosis [J]. Shock, 2009, 31(3): 238-244. DOI: 10.1097/SHK.0b013e3181834991.
|
[19] |
Tajalli-Nezhad S, Karimian M, Beyer C, et al. The regulatory role of Toll-like receptors after ischemic stroke: neurosteroids as TLR modulators with the focus on TLR2/4 [J]. Cell Mol Life Sci, 2019, 76(3): 523-537. DOI: 10.1007/s00018-018-2953-2.
|
[20] |
Zhong CK, Yang JY, Xu T, et al. Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke [J]. Neurology, 2017, 22;89(8): 805-812. DOI: 10.1212/WNL.0000000000004257.
|
[21] |
McColl BW, Rothwell NJ, Allan SM. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms [J]. J Neurosci, 2007, 27(16): 4403-4412. DOI: 10.1523/JNEUROSCI.5376-06.2007.
|
[22] |
Kuol N, Stojanovska L, Nurgali K, et al. PD-1/PD-L1 in disease [J]. Immunotherapy, 2018, 10(2): 149-160. DOI: 10.2217/imt-2017-0120.
|
[23] |
Gelderblom M, Weymar A, Bernreuther C, et al. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke [J]. Blood, 2012, 120(18): 3793-3802. DOI: 10.1182/blood-2012-02-412726.
|
[24] |
Shichita T, Sugiyama Y, Ooboshi H, et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury [J]. Nat Med, 2009, 15(8): 946-950. DOI: 10.1038/nm.1999.
|
[25] |
Cai W, Liu SX, Hu MY, et al. Functional dynamics of neutrophils after ischemic stroke [J]. Transl Stroke Res, 2020, 11(1): 108-121. DOI: 10.1007/s12975-019-00694-y.
|
[26] |
Wu ZQ, Lei K, Li HZ, et al. Transcriptome-based network analysis related to M2-like tumor-associated macrophage infiltration identified VARS1 as a potential target for improving melanoma immunotherapy efficacy [J]. J Transl Med, 2022, 20(1): 489. DOI: 10.1186/s12967-022-03686-z.
|